Patents Assigned to HBar Technologies, LLC
  • Patent number: 9630021
    Abstract: Systems and methods for using antiprotons for terminating unwanted or undesirable cells which can be used in the treatment of conditions caused by the existence and/or proliferation of such undesirable cells. Such conditions include cardiovascular ailments, Parkinson's disease, wet macular degeneration, endocrine disorders, dermatological ailments, and cancer. Because of the unique nature of antiprotons and their annihilation characteristics, the preferred antiproton delivery device (1010, 1015, 1030) embodiments further incorporate detector arrays (1050a), capable of detecting characteristic emissions in the course of treatment.
    Type: Grant
    Filed: December 26, 2011
    Date of Patent: April 25, 2017
    Assignee: HBAR TECHNOLOGIES LLC
    Inventor: Gerald Peter Jackson
  • Patent number: 9543052
    Abstract: Particle storing apparatus including only one electric field restraining charged particles, such as antiprotons, in an ultrahigh vacuum from striking a container surface for a half-life of at least 1 hour. Depending on implementation, restraining can be devoid of a magnetic field, and the container can be devoid of cryogenic cooling or need not include a dewar.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: January 10, 2017
    Assignee: HBAR TECHNOLOGIES, LLC
    Inventor: Gerald Peter Jackson
  • Patent number: 8509374
    Abstract: Method including: inducing, with antiprotons, nuclear fission in a material, such as depleted uranium; measuring leakage of radioactive byproduct produced by the fission; and producing, responsive to the measuring, a design for the nuclear fuel element. Apparatus, manufactures, and products produced by the method can be encompassed.
    Type: Grant
    Filed: November 9, 2006
    Date of Patent: August 13, 2013
    Assignee: HBar Technologies, LLC
    Inventor: Gerald Peter Jackson
  • Patent number: 8109865
    Abstract: Systems and methods for using antiprotons for terminating unwanted or undesirable cells which can be used in the treatment of conditions caused by the existence and/or proliferation of such undesirable cells. Such conditions include cardiovascular ailments, Parkinson's disease, wet macular degeneration, endocrine disorders, dermatological ailments, and cancer. Because of the unique nature of antiprotons and their annihilation characteristics, the preferred antiproton delivery device (1010, 1015, 1030) embodiments further incorporate detector arrays (1050a), capable of detecting characteristic emissions in the course of treatment.
    Type: Grant
    Filed: February 5, 2007
    Date of Patent: February 7, 2012
    Assignee: Hbar Technologies, LLC
    Inventor: Gerald Peter Jackson
  • Patent number: 6838676
    Abstract: A method for slowing and controlling a beam of charged particles includes the steps of superimposing at least one magnetic field on a mass and passing the beam through the mass and at least one magnetic field such that the beam and the mass slows but does not stop the particles. An apparatus for slowing and controlling a beam of charged particles includes a bending magnetic field superimposed on a focusing magnetic field within a mass.
    Type: Grant
    Filed: July 21, 2003
    Date of Patent: January 4, 2005
    Assignee: HBar Technologies, LLC
    Inventor: Gerald P. Jackson
  • Patent number: RE46383
    Abstract: A method for using a synchrotron, the method including the steps of: providing a synchrotron designed to accelerate a hadron beam to higher momenta; altering said synchrotron to enable deceleration of hadron beams to lower momenta; and using the synchrotron in said altering step in decelerating a hadron beam to lower momentum.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: May 2, 2017
    Assignee: HBAR TECHNOLOGIES, LLC
    Inventor: Gerald Peter Jackson